Dai Ichi Life Insurance Company Ltd increased its stake in shares of Monsanto Company (NYSE:MON) by 0.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 48,613 shares of the basic materials company’s stock after acquiring an additional 214 shares during the quarter. Dai Ichi Life Insurance Company Ltd’s holdings in Monsanto were worth $5,754,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Puplava Financial Services Inc. raised its holdings in Monsanto by 0.4% during the second quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock worth $251,000 after buying an additional 9 shares during the last quarter. Savant Capital LLC raised its holdings in Monsanto by 0.4% during the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock worth $349,000 after buying an additional 11 shares during the last quarter. Guardian Life Insurance Co. of America raised its holdings in Monsanto by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock worth $191,000 after buying an additional 11 shares during the last quarter. Enterprise Financial Services Corp raised its holdings in Monsanto by 1.2% during the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock worth $164,000 after buying an additional 16 shares during the last quarter. Finally, Forward Management LLC raised its holdings in Monsanto by 0.5% during the second quarter. Forward Management LLC now owns 3,201 shares of the basic materials company’s stock worth $379,000 after buying an additional 16 shares during the last quarter. 74.78% of the stock is currently owned by institutional investors and hedge funds.

Monsanto Company (MON) opened at 118.27 on Monday. The company has a market cap of $51.96 billion, a price-to-earnings ratio of 25.54 and a beta of 1.07. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $118.97. The firm’s 50-day moving average is $117.25 and its 200-day moving average is $116.44.

Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.19. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The firm had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. During the same quarter in the prior year, the firm earned $2.17 EPS. The business’s revenue for the quarter was up 1.0% compared to the same quarter last year. On average, analysts anticipate that Monsanto Company will post $4.89 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 1.83%. The ex-dividend date is Thursday, October 5th. Monsanto’s payout ratio is currently 46.75%.

COPYRIGHT VIOLATION WARNING: “Monsanto Company (MON) Shares Bought by Dai Ichi Life Insurance Company Ltd” was first published by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/09/18/monsanto-company-mon-shares-bought-by-dai-ichi-life-insurance-company-ltd.html.

In other news, EVP Steven Mizell sold 11,300 shares of the company’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the sale, the executive vice president now owns 55,011 shares of the company’s stock, valued at approximately $6,522,654.27. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert T. Fraley sold 52,410 shares of the company’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $117.95, for a total transaction of $6,181,759.50. The disclosure for this sale can be found here. 0.79% of the stock is owned by corporate insiders.

Several research firms have weighed in on MON. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Royal Bank Of Canada restated a “sector perform” rating and set a $128.00 price objective (up previously from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Barclays PLC upped their price objective on shares of Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a report on Thursday, June 29th. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, July 4th. Finally, Jefferies Group LLC restated a “hold” rating and set a $128.00 price objective on shares of Monsanto in a report on Friday. Ten analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Monsanto presently has an average rating of “Hold” and a consensus price target of $124.09.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.